Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Competing interests The authors declare that there is no conflict of interest
SARC031: A Phase 2 Trial of the MEK Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Combination with the mTOR Inhibitor Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors PI: AeRang Kim, M.D., Ph.D
This article did not locate the specific cancellation deadline or notice-period language for the recurring option on the pages reviewed
Professional Support for Weight Management Programs Sometimes, your doctor might recommend a more structured weight management program
SEMAGLUTIDE, a drug widely used for the management of type 2 diabetes and weight loss, has been linked to a concerning rise in fatalities, prompting a warning from the CEO of Novo Nordisk, the drugs manufacturer
US$ 24.98
US$ 27.05
US$ 26.77
US$ 26.36
US$ 21.38
US$ 20.88
US$ 24.82
US$ 20.11
US$ 20.55
